Yes, love to hear first patient with TNBC injected
Post# of 144805
With the 8 cancer indications all at once, I assume that also spreads an extremely wide net with potential partners. Kind of a shot across the bow to the BPs in cancer.
“will host an investment community conference call to provide a business update, including current licensing opportunities, as well as the recently announced multi-pathway approach to concurrently explore leronlimab’s ability to block CCR5 in its role for potentially 8 cancer indications.”
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)